UBS AM

UBS AM’s Stemline Therapeutics, Inc. STML Stock Holding History

UBS AM’s Portfolio STML Stock Details STML Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell
2020 Q1	$188K	Sell
2019 Q4	$417K	Buy
2019 Q3	$328K	Buy
2019 Q2	$272K	Hold
2019 Q1	$229K	Buy
2018 Q4	$1.78K	Hold
2018 Q3	$3.1K	Hold
2018 Q2	$3K	Buy